Fishawack

Brighton, United Kingdom Founded: 2001 • Age: 25 yrs Unicorn Acquired By Bridgepoint Capital
Fully integrated cross-border services are delivered to global pharmaceutical organizations.

About Fishawack

Fishawack is a Healthcare company based in Brighton (United Kingdom) founded in 2001, and was acquired by Bridgepoint Capital in April 2020. It operates as a fully integrated cross-border services are delivered to global pharmaceutical organizations. Fishawack has raised $23.59 million across 3 funding rounds from investors including LDC, Bridgepoint Capital and YFM Equity Partners. The company has 45 employees. Fishawack has completed 13 acquisitions, including 2E Creative, Avalere Health and Avalere Health. Fishawack was last valued at $4.33 billion in February 2021. Fishawack offers products and services including Consulting Services, Data and Technology Services, and Media Services. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its legal entity is FISHAWACK LIMITED. Its competitors include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group and 3 more; 3 of its 8 listed competitors have raised funding.

Company details

Fishawack was founded in 2001 and is headquartered in Brighton, United Kingdom. Operations focus on the pharmaceutical sector, where fully integrated services are offered across borders to support global organizations. These services encompass strategic consulting, market access, and communications, enabling clients to navigate international regulatory and commercial challenges. The company maintains a presence that facilitates worldwide engagement without regional limitations.

  • Headquarters Brighton, United Kingdom
  • Employees 45
  • Stage Unicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website fishawack.com
  • Social LinkedIn X
  • Acquired by Bridgepoint Capital (Apr 2020)
  • Legal Name Fishawack Limited
  • Date of Incorporation 22 Nov, 2016
  • Jurisdiction KNUTSFORD, CHESHIRE, ENGLAND
Key Metrics
  • Annual Revenue
    $145.17 M (USD)
    0
    as on Mar 31, 2019
  • Net Profit
    $2.57 K (USD)
    100
    as on Mar 31, 2020
  • EBITDA
    $3.02 K (USD)
    100
    as on Mar 31, 2020
  • Total Equity Funding
    $23.59M (USD)

    in 3 rounds

  • Latest Funding Round
    $22M (USD), Series A

    Mar 2021

  • Investors
    LDC

    & 3 more

  • Employee Count
    45
  • Investments & Acquisitions
    2E Creative

    & 12 more

  • Acquired by
    Bridgepoint Capital

    & 3 more

    (Apr 2020)

Products & Services of Fishawack

Fishawack offers a comprehensive portfolio of products and services, including Consulting Services, Data and Technology Services, and Media Services.

Consulting Services
Healthcare Consulting

Offers expertise in medical policy and access strategies.

Data and Technology Services
Technology Solutions

Provides data management and evidence analysis for healthcare.

Media Services
Marketing and Media

Delivers strategies for healthcare communication and outreach.

Funding Insights of Fishawack

Fishawack has successfully raised a total of $23.59M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $23.59M
  • Total Rounds 3
  • Last Round Series A β€” $22M
  • First Round $1.1M

    (Mar 2020)

All 3 funding rounds of Fishawack with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2021$22MSeries A––
–
Feb 2021$488,000Seed$4.33B–
–
Mar 2020$1.1MSeed$4.06B–
–
Valuation history
DateValuationStage
Feb 2021$4.33Bβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2020$4.06Bβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $4.33B (Feb 2021). 4 investors in total: 4 institutional.

Investors in Fishawack

Fishawack has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include LDC, Bridgepoint Capital and YFM Equity Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investments are focused on multiple sectors for growth.
1981ldc.co.ukLondon, United Kingdom
Private equity firm focused on multiple sectors
1982yfmep.comLeeds, United Kingdom
Private equity firm focused on SMEs
–growthcapital.co.ukLondon, United Kingdom
Middle-market businesses up to €1 billion are acquired pan-Europe.
1984bridgepoint.euFrankfurt, Germany
Premium access

Investor details for Fishawack

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Fishawack

256 people are tracked at Fishawack (131 in leadership, 125 in team); the tracked headcount is 45.

NameRoleGroup
Gail Louise Flockhart
–Leadership
Rachel Davies
–Leadership
Jenifer Kirkland
–Leadership
David Matthew Snowball
–Leadership
Gregory Jones
Associate Creative Director, ArtLeadership
David Russell
Senior Art DirectorLeadership
Andrew Runion
Associate Creative DirectorLeadership
Sharon Burdett
Creative DirectorLeadership
Sonie Modino
Group Head Of CopyLeadership
Dan Dinsmore
Senior Art DirectorLeadership
Perry Bason
Senior Art DirectorLeadership
Caleb Finn
Senior Art DirectorLeadership
Tobi Adewale
Senior Director StrategyLeadership
Gina Chambers
Sr Business Director -learning And DevelopmentLeadership
Kevin MacKiw
Vice PresidentLeadership
Ryan Mason
Chief Strategy Officer, Avalere HealthLeadership
Sarah Hall
PresidentLeadership
Jamie Thompson
Group Creative DirectorLeadership
Jack Dixon
Talent Director (talent Acquisition)Leadership
Amy Klug
Vp, Group Account DirectorLeadership

236 more people are available in the full profile.

Premium access

Complete people profiles for Fishawack

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fishawack

Fishawack has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include 2E Creative, Avalere Health and Avalere Health.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Analytic and strategic problems are solved for healthcare companies.
avalere.com–2000Jun 2022β€’β€’β€’β€’
Health-economics and outcomes research consultancy services are provided.
pai2.comBrookline, United States1973Mar 2022β€’β€’β€’β€’
Provider of clinical development and product planning software
heroapps.ioBrookline, United States2015Mar 2022β€’β€’β€’β€’
Healthcare marketing services are provided to clients.
closerlook.comChicago, United States1996Jun 2021β€’β€’β€’β€’
Market access consulting is provided to the biopharma sector.
prmaconsulting.comFleet, United Kingdom2006Mar 2021β€’β€’β€’β€’
Healthcare marketing, advertising, and communication services are provided.
hivehealth.comLondon, United Kingdom2007Jan 2021β€’β€’β€’β€’
Biopharma consulting services are provided by Skysis to industry clients.
skysis.comScottsdale, United States2011Apr 2020β€’β€’β€’β€’
Healthcare branding services are specialized in and provided to clients.
meet2e.comSt. Louis, United States1999Aug 2019β€’β€’β€’β€’
Provider of healthcare marketing and consulting services
2ecreative.comSt. Louis, United States1999Aug 2019β€’β€’β€’β€’
Healthcare marketing and advertising services are provided by Dudnyk.
dudnyk.comHorsham, United States1993Mar 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for Fishawack

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Fishawack

18 dated milestones of Fishawack across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Fishawack is founded.
  2. Exit Acquired by YFM Equity Partners.
  3. Exit Acquired by Growth Capital Partners.
  4. Exit Acquired by LDC.
  5. Acquisition Acquires Dudnyk.
  6. Acquisition Acquires 2E Creative.
  7. Acquisition Acquires Meet2E.
  8. Funding First funding round of $1.1M.
  9. Milestone Reaches Unicorn status.
  10. Acquisition Acquires Skysis.
  11. Exit Acquired by Bridgepoint Capital.
  12. Acquisition Acquires Avalere Health.
  13. Funding Latest funding round, Series A, of $22.0M.
  14. Acquisition Acquires Avalere Health.
  15. Acquisition Acquires Closerlook.
  16. Acquisition Acquires hΔ“Ro3.
  17. Acquisition Acquires Policy Analysis.
  18. Acquisition Acquires Avalere Health.

Competitors of Fishawack

Fishawack has 8 listed competitors in our database, 3 of them funded. They include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indegene.com1998Princeton, United States$255.15M350
Suite solutions are provided for payers and healthcare providers.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
clinigengroup.com2010Burton-on-trent, United Kingdom––
Specialty medicines are supplied via clinical trials and access programs.
zuelligpharma.com1992Singapore––
Healthcare access in Asia is enhanced by Zuellig Pharma.
sciencegroup.com1995Cambridge, United Kingdom–431
Technology-based consultancy and product development services are provided.
clearviewhcp.com2008Newton, United States–381
Strategic consulting services are provided to life sciences companies.
diaceutics.com2005Belfast, United Kingdom–133
Precision medicine integration is facilitated through analytics and services.
sancilio.com2005Riviera Beach, United States$27.25M–
Innovative drug candidates are developed using proprietary Advanced Lipid Technologies.
Premium access

Detailed competitors of Fishawack

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as Fishawack (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fishawack

Premium access

Complete news archive for Fishawack

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fishawack

Fishawack was founded in 2001 and raised its 1st funding round 19 years after it was founded.

Fishawack is headquartered in Brighton, United Kingdom. It is registered at Brighton, East Sussex, United Kingdom.

Fishawack is a funded company, having raised a total of $23.59M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.1M, raised on Mar 2020.

Fishawack has 45 employees.

Annual revenue of Fishawack is $145.17M as on Mar 31, 2019.

Fishawack was founded in 2001 and is headquartered in Brighton, United Kingdom. Operations focus on the pharmaceutical sector, where fully integrated services are offered across borders to support global organizations. These services encompass strategic consulting, market access, and communications, enabling clients to navigate international regulatory and commercial challenges. The company maintains a presence that facilitates worldwide engagement without regional limitations.

Fishawack's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Fishawack offers Consulting Services, Data and Technology Services, and Media Services.

Fishawack has made 13 acquisitions, including 2E Creative, Avalere Health, and Avalere Health.

Fishawack has 4 investors. Key investors include LDC, Bridgepoint Capital, YFM Equity Partners, and Growth Capital Partners.

The valuation of Fishawack is $4.33B as of Feb 2021.

Fishawack operates through Fishawack Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available